GeorgeEHarbMD

Internal Medicine • Montclair, NJ

Vitas Healthcare

Join to view full profile

Dr. Harb is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Harb's full profile

Already have an account?

Office
American University of Beirut
Montclair, NJ 07042
Is this information wrong?

Education & Training

American University of Beirut Faculty of MedicineClass of 1982

Certifications & Licensure

NJ State Medical License 1994 - 2025
NY State Medical License 1980 - 2025
FL State Medical License 1995 - 2004
PA State Medical License 1993 - 2000

Clinical Trials

Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase for Infants and Children Start of enrollment: 2007 Aug 01
Completed
Phase 4
Pharmacokinetic and Safety Study of HYLENEX Recombinant-Augmented Subcutaneous Ceftriaxone Administration Start of enrollment: 2007 Jun 01
Completed
Phase 1

Publications & Presentations

PubMed

45 citations
Safety and pharmacokinetics of subcutaneous ceftriaxone administered with or without recombinant human hyaluronidase (rHuPH20) versus intravenous ceftriaxone administr...
George Harb, Francois Lebel, Jean P. Battikha, Jeffrey W Thackara> ;Current Medical Research and Opinion. 2010 Jan 15
23 citations
Prolonged survival of microencapsulated neonatal porcine islets in mice treated with a combination of anti-CD154 and anti-LFA-1 monoclonal antibodies.
Tsunehiro Kobayashi, George Harb, Gina R. Rayat> ;Transplantation. 2005 Sep 27
695 citations
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.
Raymond T. Chung, Janet Andersen, Paul A. Volberding, Gregory K. Robbins, Tun Liu, Kenneth E. Sherman, Marion G. Peters, Margaret James Koziel, Atul K. Bhan, Beverly A...> ;The New England Journal of Medicine. 2004 Jul 29
4 citations
Population pharmacokinetics of didanosine in patients with human immunodeficiency virus infection.
George E. Harb, Jaap W. Mandema, Tom Delahunty, Neal B. Benowitz, Rebecca L. Coleman, Lewis B. Sheiner, Mark A. Jacobson> ;The Journal of Infectious Diseases. 1996 Jan 1
34 citations
Central venous catheter infections in AIDS patients receiving treatment for cytomegalovirus disease.
H D Stanley, Edwin D. Charlebois, George E. Harb, Mark A. Jacobson> ;Journal of Acquired Immune Deficiency Syndromes. 1994 Mar 1
24 citations
Pharmacoepidemiology of adverse drug reactions in hospitalized patients with human immunodeficiency virus disease
George E. Harb, Alldredge Bk, Rebecca L. Coleman, Mark A. Jacobson> ;Journal of Acquired Immune Deficiency Syndromes. 1993 Aug 1
35 citations
Human immunodeficiency virus (HIV) infection : does it increase susceptibility to adverse drug reactions ?
George E. Harb, Mark A. Jacobson> ;Drug Safety. 1993 Jul 1
23 citations
Survival of patients with AIDS and cytomegalovirus disease treated with ganciclovir or foscarnet.
George E. Harb, Peter Bacchetti, Mark A. Jacobson> ;AIDS. 1991 Aug 1
Join now to see all

GeorgeEHarbMD

Dr. Harb is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Viewing the full profile is available to verified healthcare professionals only.